Symbol Name ID |
Tnfaip3
tumor necrosis factor, alpha-induced protein 3 MGI:1196377 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Lymphopenia |
Colitis |
Anterior uveitis |
Skin rash |
Antinuclear antibody positivity |
Lupus anticoagulant |
Disease(s) Associated with TNFAIP3 | ||||||
familial Behcet-like autoinflammatory syndrome |
Mouse Phenotypes | immune system phenotype |
decreased B cell apoptosis |
increased B cell proliferation |
increased susceptibility to induced colitis |
intestinal inflammation |
thymus atrophy |
enlarged spleen |
increased immature B cell number |
abnormal myelopoiesis |
myeloid hyperplasia |
increased granulocyte number |
abnormal B cell number |
increased germinal center B cell number |
decreased mature B cell number |
decreased B-1a cell number |
decreased B-1b cell number |
decreased marginal zone B cell number |
increased follicular B cell number |
increased plasma cell number |
decreased B cell number |
increased B cell number |
increased CD4-positive, alpha-beta T cell number |
increased CD8-positive, alpha-beta T cell number |
increased effector memory T-helper cell number |
increased T cell number |
increased lymphocyte cell number |
increased macrophage cell number |
abnormal B cell morphology |
abnormal B-1a B cell morphology |
abnormal spleen morphology |
increased splenocyte number |
pale spleen |
abnormal B cell activation |
increased IgA level |
increased IgG2a level |
increased IgG level |
increased IgM level |
increased immunoglobulin level |
increased microglial cell activation |
abnormal circulating cytokine level |
increased circulating interferon-gamma level |
abnormal circulating interleukin level |
increased circulating interleukin-1 beta level |
increased circulating interleukin-6 level |
increased circulating tumor necrosis factor level |
enlarged lymph nodes |
abnormal cytokine secretion |
abnormal chemokine secretion |
decreased interleukin-6 secretion |
increased interleukin-6 secretion |
increased susceptibility to autoimmune disorder |
increased autoantibody level |
increased anti-nuclear antigen antibody level |
abnormal inflammatory response |
increased inflammatory response |
CNS inflammation |
joint inflammation |
liver inflammation |
kidney inflammation |
uterus inflammation |
lung inflammation |
|
Availability | Mouse Genotype | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tnfaip3m1Apb/Tnfaip3m1Apb | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tnfaip3tm1.1Gho/Tnfaip3tm1.1Gho | * | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tnfaip3tm1Ama/Tnfaip3tm1Ama | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tnfaip3tm3.1Ama/Tnfaip3tm3.1Ama | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tnfaip3tm4.1Ama/Tnfaip3tm4.1Ama | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cd19tm1(cre)Cgn/Cd19+ Tnfaip3tm1.1Awai/Tnfaip3tm1.1Awai (conditional) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum/0 (conditional) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tnfaip3tm1Homy/Tnfaip3tm1Homy Tg(Mx1-cre)1Cgn/? (conditional) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gt(ROSA)26Sortm9(cre/ESR1)Arte/? Tnfaip3tm1Homy/Tnfaip3tm1Homy (conditional) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tnfaip3tm2Ama/Tnfaip3tm2Ama Cd19tm1(cre)Cgn/Cd19+ (conditional) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cd19tm1(cre)Cgn/Cd19+ Tnfaip3tm2Ama/Tnfaip3+ (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|